|
15 Sep 2025 |
Nippon Life Asset Mgmt
|
Consensus Share Price Target
|
827.70 |
871.15 |
- |
5.25 |
buy
|
|
|
|
|
01 Aug 2022
|
Nippon Life Asset Mgmt
|
Keynote Capitals Ltd
|
827.70
|
411.00
|
299.35
(176.50%)
|
|
Buy
|
|
|
Quarterly Update Q1FY23
|
|
27 Jul 2022
|
Nippon Life Asset Mgmt
|
Keynote Capitals Ltd
|
827.70
|
411.00
|
286.65
(188.75%)
|
|
Buy
|
|
|
Initiating Coverage Report
|
|
27 Apr 2022
|
Nippon Life Asset Mgmt
|
Yes Securities
|
827.70
|
450.00
|
311.35
(165.84%)
|
|
Buy
|
|
|
|
|
27 Apr 2022
|
Nippon Life Asset Mgmt
|
Axis Direct
|
827.70
|
410.00
|
320.60
(158.17%)
|
|
Buy
|
|
|
We maintain a BUY with a target price of Rs 410 (25x FY24E EPS), implying an upside of 25% from the CMP.
|
|
28 Jan 2022
|
Nippon Life Asset Mgmt
|
Axis Direct
|
827.70
|
440.00
|
336.25
(146.16%)
|
|
Buy
|
|
|
We maintain our BUY rating with a target price of Rs 440 (30x FY23E EPS).
|
|
27 Oct 2021
|
Nippon Life Asset Mgmt
|
Axis Direct
|
827.70
|
485.00
|
435.10
(90.23%)
|
|
Buy
|
|
|
We maintain our BUY rating with a target price of Rs 485 (32x FY23E EPS).
|
|
08 Sep 2021
|
Nippon Life Asset Mgmt
|
Axis Direct
|
827.70
|
485.00
|
435.80
(89.93%)
|
|
Buy
|
|
|
Long-term prospects of the Indian AMC industry continue to be positive given its low penetration levels vis--vis developed countries. On sustained cost controls and improved outlook, we maintain our BUY rating with a target price of Rs 485 (32x FY23E EPS).
|
|
02 Aug 2021
|
Nippon Life Asset Mgmt
|
Axis Direct
|
827.70
|
455.00
|
400.40
(106.72%)
|
Target met |
Buy
|
|
|
We recommend a BUY with TP of Rs 455/share.
|
|
21 Jul 2021
|
Nippon Life Asset Mgmt
|
ICICI Securities Limited
|
827.70
|
480.00
|
397.90
(108.02%)
|
|
Buy
|
|
|
India with an AUM size of | 3.79 lakh crore. The company has a strong distribution network with ~80000 distributors. Market share as on Q1FY22 was at 7.2%...
|
|
20 Jul 2021
|
Nippon Life Asset Mgmt
|
Axis Direct
|
827.70
|
455.00
|
397.90
(108.02%)
|
Target met |
Buy
|
|
|
On sustained cost controls and improved outlook, we maintain our Buy rating with a target price of Rs 455 (30x FY23E EPS), implying an upside of 12%.
|